Drugs, diet and AI: the ‘gamechanger’ new findings on tackling heart conditions

The 2025 European Society of Cardiology annual meeting, the world's largest heart conference, highlighted five key areas that are considered a "turning point" in cardiology and patient care. Attended by 33,000 health professionals from 169 countries, the event featured over 1,100 sessions showcasing "gamechanger" research, new guidelines, and groundbreaking trials. The highlighted areas include the use of drugs, diet, and artificial intelligence (AI) in tackling heart conditions. Researchers presented findings on novel pharmacological interventions, the impact of dietary changes, and the application of AI-powered tools for diagnosis and treatment. These advancements are expected to significantly improve the understanding, prevention, and management of various heart-related diseases. The conference served as a platform for sharing these cutting-edge developments, which are poised to transform the field of cardiology and enhance the quality of patient care worldwide.